Investigators at Fox Chase Cancer Center have a new study available for men with a recent diagnosis of localized prostate cancer (meaning the cancer is contained in the prostate and has not spread). There are a variety of treatment options available for the...

A common sexual side effect men face after prostate cancer surgery is erectile dysfunction (the inability to achieve or sustain an erection suitable for sexual intercourse often caused by medications, chronic illnesses or poor blood flow to the penis). I...

My research staff and I at Fox Chase Cancer Center have recently launched a new study called PROGRESS (Prostate Cancer Online Guide& Resources for Electronic Survivorship Service) for men who have completed prostate cancer treatment within the last year...

Prostate cancer is the second leading cause of cancer death in men in the United States. The Federal Drug Administration (FDA) approved a type of blood test, prostate specific antigen (PSA), in 1986.Since then, PSA has been widely used for prostate cancer s...

In a recent article in the Journal of the American Medical Association, entitled, “Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement,” a group of experts discussed the findings from a National Cancer Institute working group desig...

The management of clinically localized prostate cancer, or cancer that has not spread beyond the prostate gland, is complex. There are a number of treatment options, ranging from close observation with frequent reassessment (active surveillance), surgery, a...